Upsher Smith Laboratories, Inc.

Maple Grove, MN, United States

6

Total Recalls

0

Class I Recalls

0

Ongoing Recalls

Recalls by Upsher Smith Laboratories, Inc.

FDA Drug Class II Terminated

Bexarotene Capsules, 75 mg, 100 capsules per bottle, Rx Only, Manufactured for: Upsher-Smith Laboratories, LLC, Maple Grove, MN 55369. NDC: 0832-0285-00

July 29, 2019 Upsher Smith Laboratories, Inc. 166 bottles units
FDA Drug Class II Terminated

Bumetanide Tablets, USP, 2 mg, 100-count bottle, Rx only, Manufactured by: Upser-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC 0832-0542-11

September 19, 2018 Upsher Smith Laboratories, Inc. 29,080 bottles units
FDA Drug Class II Terminated

Bumetanide Tablets, USP, 1 mg, 100-count bottle, Rx only, Manufactured by: Upser-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC 0832-0541-11

September 19, 2018 Upsher Smith Laboratories, Inc. 44,764 bottles units
FDA Drug Class III Terminated

Oxandrolone Tablets, USP, 10 mg, Rx Only, C-III, 60-count bottle, Manufactured for: Upsher-Smith Labs, Minneapolis, MN 55447, by: Pharmaceutics International, Inc., Hunt Valley, MD 21031, NDC 0245-027

April 14, 2014 Upsher Smith Laboratories, Inc. 1,185 bottles units
FDA Drug Class III Terminated

Divalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 100-count tablets per bottle, Rx only, Manufactured by Upsher-Smith Laboratories, Inc., Minneapolis, MN 55447, NDC 0245-0

December 10, 2012 Upsher Smith Laboratories, Inc. 11,316 bottles units
FDA Drug Class II Terminated

Propranolol Hydrochloride Extended-release Capsules, USP, 80 mg, 100 Capsules, Rx only, Manufactured for Upsher Smith Laboratories, Inc Minneapolis MN 55447 --- NDC 0245-0085-11, UPC 3 0245-0085-11

November 20, 2012 Upsher Smith Laboratories, Inc. 60 bottles units